4.1 Article

An Improved Protocol for Establishment of AML Patient- Derived Xenograft Models

期刊

STAR PROTOCOLS
卷 1, 期 3, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.xpro.2020.100156

关键词

-

资金

  1. Cancer Australia [1165516]
  2. Leukaemia Foundation of Australia
  3. Tour de Cure Senior Research [RSP-024-2018]

向作者/读者索取更多资源

Patient-derived xenografts (PDXs) are the most valuable tool for preclinical drug testing because they retain the genetic diversity and phenotypic heterogeneity of the original tumor. Acute myeloid leukemia (AML) remains difficult to engraft in immunodeficient mice. This is particularly true for long-term frozen patient specimens. This protocol is designed to establish PDXs of human AML with improved engraftment rates. The optimized approach increases the viability of patient cells before implantation, efficiently monitors in vivo engraftment, and maximizes bone marrow collection. For complete details on the use and execution of this protocol, please refer to Salik et al. (2020) and Lynch et al. (2019).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据